financetom
Business
financetom
/
Business
/
NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NeuroSense Therapeutics Files Prospectus for Secondary Stock Sale
Dec 6, 2024 2:32 PM

05:03 PM EST, 12/06/2024 (MT Newswires) -- NeuroSense Therapeutics ( NRSN ) late Friday disclosed plans by one of its larger institutional investors to sell a portion of its stake in the biotechnology company from time to time.

The company filed a preliminary prospectus Friday for Rimon Gold Assets to sell up to 11 million of its NeuroSense ordinary shares, including 4.4 million share it would receive by exercising warrants.

NeuroSense will not receive any proceeds from the secondary sale.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved